Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study

NCT02629575 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT02629575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02629575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study
Lead sponsor
B. Braun Melsungen AG
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2017
Enrollment
2,877 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)